Literature DB >> 4694036

Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.

P D Thomson, K L Melmon, J A Richardson, K Cohn, W Steinbrunn, R Cudihee, M Rowland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4694036     DOI: 10.7326/0003-4819-78-4-499

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  93 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Altered hepatic blood flow and drug disposition.

Authors:  A S Nies; D G Shand; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 3.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

Review 5.  Sedation for fibreoptic bronchoscopy.

Authors:  M P Shelley; P Wilson; J Norman
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

6.  Flexible fiberoptic bronchoscopy. Anesthesia, technique and results.

Authors:  E Yrigoyen; Y F Fujikawa
Journal:  West J Med       Date:  1975-02

Review 7.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

8.  Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction.

Authors:  D Oltmanns; A Pottage; W Endell
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 9.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

10.  Effect of fiberoptic bronchoscopy on respiratory performance in patients with chronic airways obstruction.

Authors:  B G Salisbury; L F Metzger; M D Altose; N N Stanley; N S Cherniack
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.